All In MedTech

Device Trial Radar · NCT07924215

PureSee EDOF Versus ZCB00 Monofocal IOLs in Mild-to-Moderate Glaucoma

Clinical Outcomes, Contrast Sensitivity, and Patient Satisfaction Following Bilateral PureSee EDOF Versus ZCB00 Monofocal IOL Implantation in Patients With Mild to Moderate Primary Open-Angle Glaucoma: An Ambispective Investigator-Initiated Trial

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Dec 2, 2026

Primary completion

Oct 29, 2027

Study completion Oct 29, 2027

Sponsor

Lead sponsor
Mann Eye InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Sengi
First posted
Nov 9, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery in patients with mild to moderate primary open-angle glaucoma (POAG). Two cohorts are compared: patients with bilateral implantation of the TECNIS PureSee non-diffractive extended depth of focus intraocular lens (EDOF IOL) and patients with bilateral implantation of the TECNIS ZCB00 monofocal IOL.

Conditions

  • Primary Open-Angle Glaucoma

Interventions

  • TECNIS PureSee Intraocular LensDevice

    Bilateral implantation of the TECNIS PureSee non-diffractive extended depth of focus intraocular lens (toric and non-toric) at cataract surgery.

  • TECNIS ZCB00 Monofocal Intraocular LensDevice

    Bilateral implantation of the TECNIS Monofocal Intraocular Lens ZCB00 (toric and non-toric) at cataract surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Distance visual acuity - binocular distance-corrected visual acuity (DCVA)Time frame: 3 to 18 months following second-eye cataract surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mann Eye Institute

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.